Oral doxycycline may be a promising therapeutic strategy targeting the inflammatory component of DR. Furthermore , study results suggest that FDP , which primarily measures inner retinal function , is responsive to intervention and may be a useful clinical trial end point for proof-of-concept studies in patients with DR.